Co-Founder and VP, Business Development at ABOzymes Biomedical - commercializing enzymes to overcome the ABO blood type barrier for blood transfusions and organ transplants.
E: [email protected]
Invited by: Taylor Raborn
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
October 31, 2023 | 94 | -1 | -1.1% |
July 19, 2022 | 95 | +1 | +1.1% |
May 06, 2022 | 94 | +1 | +1.1% |
October 07, 2021 | 93 | +1 | +1.1% |
August 26, 2021 | 92 | +8 | +9.6% |